Popular Filters
Trials With No Placebo
Enzyme
Surgery + Xiaflex + RestoreX for Peyronie's Disease
This trial compares enzyme injections with a stretching device to surgery with a stretching device for men with Peyronie's Disease. The enzyme helps dissolve scar tissue, while surgery corrects curvature. Both methods use a stretching device to help reshape and maintain the penis.
Platelet-Rich Plasma
PRP for Peyronie's Disease
This trial studies the effects of PRP injections in men with Peyronie's Disease. PRP is made from a person's own blood and contains growth factors that help heal tissues. The goal is to see if PRP can reduce scar tissue and improve symptoms. PRP is a relatively new approach in regenerative medicine, derived from a patient's own blood and rich in growth factors that promote tissue healing.
Frequently Asked Questions
Introduction to peyronie's disease
What are the top hospitals conducting peyronie's disease research?
In the realm of medical research, hospitals around the world are actively engaged in finding innovative solutions for a condition known as Peyronie's disease. One notable institution leading the charge is the University of Miami in sunny Miami, Florida. With two ongoing clinical trials and a total of two recorded trials dedicated to understanding and treating this condition, they have made significant strides since their first trial in 2021. Meanwhile, The Male Fertility and Peyronie's Clinic located in Orem offers another promising avenue for patients seeking relief from this disorder. They too have two active trials underway and share an impressive record of two completed studies since initiating their first trial in 2020.
For those seeking specialized expertise within urology institutes, look no further than the University of Miami - Desai Sethi Urology Institute also situated in Miami. While currently conducting one active peyronie's disease trial, they have demonstrated commitment to advancing knowledge through their singular recorded study that began its journey towards progress in 2023.
Expanding beyond borders brings us to Mayo Clinic Florida nestled within Jacksonville; here researchers strive to enhance understanding by undertaking one active clinical trial while having achieved valuable insights from a single previous investigation commencing back during 2022.
Lastly yet not least significant is Diamond Health Care Centre based out of Vancouver where they currently focus on investigating peyronie's disease with one ongoing clinical test following completion of an earlier groundbreaking endeavor initiated just last year during 2021.
These notable institutions collectively highlight our growing efforts worldwide to better comprehend and treat Peyronie's disease—an often debilitating condition affecting men—to ultimately improve patients' quality of life globally
Which are the best cities for peyronie's disease clinical trials?
When it comes to clinical trials for Peyronie's disease, several cities are at the forefront of research. Miami, Florida has 3 active trials that focus on treatments like Collagenase Clostridium Histolyticum (CCH) Group and Autologous Platelet Rich Plasma. Orem, Utah follows with 2 ongoing studies investigating CCH administration and Surgery+PTT interventions. Additionally, Jacksonville, Florida; Vancouver, British Columbia; and New york City each have one active trial exploring different treatment approaches for this condition. These cities offer individuals with Peyronie's disease opportunities to participate in cutting-edge clinical trials that may lead to advancements in care for this challenging condition.
Which are the top treatments for peyronie's disease being explored in clinical trials?
Clinical trials are shedding light on potential breakthrough treatments for Peyronie's disease. The top contenders include a CT exam, currently being explored in one active trial and marking its first listing in 2022. Another promising option is CCH administration, also in one ongoing trial since it was introduced to the scene in 2021. Additionally, autologous Platelet Rich Plasma (PRP) shows promise with its own active trial and first listing alongside CCH administration in 2021. These innovative therapies offer hope for individuals dealing with Peyronie's disease, bringing us closer to improved treatment options and quality of life for patients worldwide.
What are the most recent clinical trials for peyronie's disease?
Exciting advancements in the field of Peyronie's disease have emerged through recent clinical trials, offering hope for individuals affected by this condition. One such trial investigates the administration of CCH (collagenase clostridium histolyticum) as a potential treatment option. Phase 4 studies provide valuable insights into its effectiveness and safety profile. Additionally, autologous platelet-rich plasma therapy has shown promise in Phase 2 trials, demonstrating its potential to address the symptoms associated with Peyronie's disease. Furthermore, surgical intervention combined with penile traction therapy is being explored in a Phase 4 trial to assess its efficacy as an approach for managing the condition. With ongoing research and innovation driving progress forward, new strategies are on the horizon to better support those living with Peyronie's disease.
What peyronie's disease clinical trials were recently completed?
Recently completed clinical trials have made significant strides in the field of Peyronie's disease, offering hope for individuals affected by this condition. Prominent among these trials is a study sponsored by Auxilium Pharmaceuticals that investigated the efficacy of Xiaflex as a potential treatment for Peyronie's disease. Another notable trial focused on Collagenase Clostridium Histolyticum (CCH), with XIAPEX being the investigational drug involved; this trial was sponsored by Swedish Orphan Biovitrum AB. These recent advancements signify crucial progress in understanding and addressing Peyronie's disease, providing encouragement to patients seeking effective therapies.